StockData
AARDNasdaqPharmaceutical PreparationsFiscal year ends December 31

Aardvark Therapeutics, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$3.74−0.04 (-1.06%)

Close on Oct 19, 2026

Market cap
$81.70M
P/E (TTM)
–
Dividend yield
–

SEC filings

33 of Aardvark Therapeutics's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report8-KOct 23, 2026Oct 23, 2026SEC EDGAR
Current report8-KOct 22, 2026Oct 22, 2026SEC EDGAR
Current report8-KOct 6, 2026Oct 8, 2026SEC EDGAR
Current report8-KAug 14, 2026Aug 17, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 11, 2026SEC EDGAR
Current report8-KAug 11, 2026Aug 11, 2026SEC EDGAR
Proxy statementDEF 14AAug 14, 2026Jul 10, 2026SEC EDGAR
Current report8-KJun 10, 2026Jun 12, 2026SEC EDGAR
Current report8-KMay 14, 2026May 14, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 7, 2026SEC EDGAR
Current report8-KMay 7, 2026May 7, 2026SEC EDGAR
Current report8-KMar 23, 2026Mar 24, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 23, 2026SEC EDGAR
Current report8-KMar 23, 2026Mar 23, 2026SEC EDGAR
Current report8-KFeb 27, 2026Feb 27, 2026SEC EDGAR
Current report8-KFeb 9, 2026Feb 12, 2026SEC EDGAR
Current report8-KFeb 10, 2026Feb 10, 2026SEC EDGAR
Current report8-KJan 12, 2026Jan 12, 2026SEC EDGAR
Current report8-KDec 10, 2025Dec 10, 2025SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 13, 2025SEC EDGAR
Current report8-KNov 13, 2025Nov 13, 2025SEC EDGAR
Current report8-KNov 5, 2025Nov 6, 2025SEC EDGAR
Current report8-KNov 4, 2025Nov 4, 2025SEC EDGAR
Current report8-KOct 8, 2025Oct 9, 2025SEC EDGAR
Current report8-KSep 2, 2025Sep 3, 2025SEC EDGAR
Quarterly report10-QJun 30, 2025Aug 13, 2025SEC EDGAR
Current report8-KAug 13, 2025Aug 13, 2025SEC EDGAR
Current report8-KAug 12, 2025Aug 12, 2025SEC EDGAR
Quarterly report10-QMar 31, 2025May 14, 2025SEC EDGAR
Current report8-KMay 14, 2025May 14, 2025SEC EDGAR
Annual report10-KDec 31, 2024Mar 31, 2025SEC EDGAR
Current report8-KMar 31, 2025Mar 31, 2025SEC EDGAR
Current report8-KFeb 14, 2025Feb 14, 2025SEC EDGAR